3 Results for "

PASMC

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "PASMC" in MCE Product Catalog:

2
2 Cited Publications
Referencia número: HY-120295
No. CAS: 195529-54-5
Pureza:  99.51%
Áreas de investigación:  

Cardiovascular Disease Endocrinology

A-192621, a chemical probe, is a potent, nonpeptide, orally active and selective endothelin B (ETB) receptor antagonist with an IC50 of 4.5 nM and a Ki of 8.8 nM. The selectivity of A-192621 is 636-fold higher than ETA (IC50 of 4280 nM and Ki of 5600 nM). A-192621 promotes apoptosis in PASMCs. A-192621 alos causes elevation of arterial blood pressure and an elevation in the plasma ET-1 level .
loading...
    loading...
Referencia número: HY-108069
No. CAS: 642407-63-4
Pureza:  ≥98.0%
Target:  

Potassium Channel nAChR

Áreas de investigación:  

Neurological Disease

Iptakalim hydrochloride, a lipophilic para-amino compound, is a novel ATP-sensitive potassium channel (KATP) opener, as well as an α4β2-containing nicotinic acetylcholine receptor (nAChR) antagonist .
loading...
    loading...
Referencia número: HY-162888
No. CAS: 2376694-72-1
Target:  

PDGFR ERK

Áreas de investigación:  

Cardiovascular Disease

WQ-C-401 is an orally active platelet-derived growth factor receptor (PDGFR) inhibitor. WQ-C-401 inhibits cell proliferation by blocking PDGFR autophosphorylation in a concentration-dependent manner, with EC50 values of 3.5 nM for PDGFRα Y849 and 5.8 nM for PDGFRβ Y1021. Additionally, WQ-C-401 can inhibit PASMCs proliferation and migration by blocking PDGF-BB-induced ERK1/2 phosphorylation, reducing collagen I synthesis, and increasing α-SMA expression, thereby preventing pulmonary vascular remodeling. WQ-C-401 holds promise for research in the field of pulmonary arterial hypertension .
loading...
    loading...